Perfluorooctanoate exposure and major birth defects

Reproductive Toxicology

Volumn 47, Issue , 2014, Pages 15-20

  Stein, Cheryl R ^a   Savitz, David A ^b   Elston, Beth ^b   Thorpe, Phoebe G ^c   Gilboa, Suzanne M ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Congenital abnormalities; Epidemiology; Fluorocarbons; Perfluorooctanoic acid

Indexed keywords

DRINKING WATER; PERFLUOROOCTANOIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; WATER POLLUTANT;

ADULT; AMNION FLUID; ARTICLE; BIRTH DEFECT; BRAIN DISEASE; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; EYE DISEASE; FEMALE; FETUS DEVELOPMENT; FLUID INTAKE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; KIDNEY DISEASE; LIMB DISEASE; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SELF REPORT; SKULL DISEASE; UMBILICAL CORD BLOOD; UROGENITAL TRACT DISEASE; WATER CONTAMINATION; ADOLESCENT; ANALYSIS; BLOOD; BRAIN; CONGENITAL ABNORMALITIES; CONGENITAL MALFORMATION; ENVIRONMENTAL EXPOSURE; MIDDLE AGED; RISK; UNITED STATES; WATER POLLUTANT; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; CAPRYLATES; CONGENITAL ABNORMALITIES; ENVIRONMENTAL EXPOSURE; FEMALE; FLUOROCARBONS; HUMANS; INFANT, NEWBORN; MIDDLE AGED; ODDS RATIO; OHIO; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 84901623074     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.04.006     Document Type: Article

References (34)

1. U.S.Environmental Protection Agency Perfluorooctanoic acid (PFOA) and fluorinated telomers 2009, U.S. Environmental Protection Agency, Washington, DC.
2. U.S.Environmental Protection Agency Perfluorooctanoic acid (PFOA) 2009, U.S. Environmental Protection Agency, Washington, DC.
3. Stahl T., Mattern D., Brunn H. Toxicology of perfluorinated compounds. Environ Sci Eur 2011, 23:38. 10.1186/2190-4715-23-38.
4. D'Eon J.C., Mabury S.A. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?. Environ Sci Technol 2011, 45:7974-7984.
5. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 2011, 45(19):8037-8045.
6. Jensen M.S., Norgaard-Pedersen B., Toft G., Hougaard D.M., Bonde J.P., Cohen A., et al. Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy. Environ Health Perspect 2012, 120(6):897-903.
7. Stein C.R., Wolff M.S., Calafat A.M., Kato K., Engel S.M. Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study. Reprod Toxicol 2011, 34(3):312-316.
8. Inoue K., Okada F., Ito R., Kato S., Sasaki S., Nakajima S., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 2004, 112:1204-1207.
9. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 2007, 80:643-648.
10. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 2008, 108:56-62.
11. Kuklenyik Z., Reich J.A., Tully J.S., Needham L.L., Calafat A.M. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol 2004, 38:3698-3704.
12. So M.K., Yamashita N., Taniyasu S., Jiang Q., Giesy J.P., Chen K., et al. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol 2006, 40:2924-2929.
13. Tao L., Kannan K., Wong C.M., Arcaro K.F., Butenhoff J.L. Perfluorinated compounds in human milk from Massachusetts, USA. Environ Sci Technol 2008, 42:3096-3101.
14. Tao L., Ma J., Kunisue T., Libelo E.L., Tanabe S., Kannan K. Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States. Environ Sci Technol 2008, 42:8597-8602.
15. Volkel W., Genzel-Boroviczeny O., Demmelmair H., Gebauer C., Koletzko B., Twardella D., et al. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. Int J Hyg Environ Health 2008, 211:440-446.
16. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007, 99:366-394.
17. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 2004, 198:231-241.
18. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 2009, 27:212-230.
19. U.S. Environmental Protection Agency. 2010/2015 PFOA Stewardship Program.
20. Bartell S.M., Calafat A.M., Lyu C., Kato K., Ryan P.B., Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 2010, 118:222-228.
21. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007, 115:1298-1305.
22. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 2003, 74:369-381.
23. Era S., Harada K.H., Toyoshima M., Inoue K., Minata M., Saito N., et al. Cleft palate caused by perfluorooctane sulfonate is caused mainly by extrinsic factors. Toxicology 2009, 256:42-47.
24. Jiang Q., Lust R.M., Strynar M.J., Dagnino S., DeWitt J.C. Perflurooctanoic acid induces developmental cardiotoxicity in chicken embryos and hatchlings. Toxicology 2012, 293:97-106.
25. Cheng W., Yu Z., Feng L., Wang Y. Perfluorooctane sulfonate (PFOS) induced embryotoxicity and disruption of cardiogenesis. Toxicol In vitro: Int J Publ Assoc BIBRA 2013, 27:1503-1512.
26. Case M.T., York R.G., Christian M.S. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol 2001, 20:101-109.
27. Frisbee S.J., Brooks A.P., Maher A., Flensborg P., Arnold S., Fletcher T., et al. The C8 health project: design, methods, and participants. Environ Health Perspect 2009, 117:1873-1882.
28. Stein C.R., Savitz D.A., Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 2009, 170:837-846.
29. Savitz D.A., Stein C.R., Bartell S.M., Elston B., Gong J., Shin H.M., et al. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 2012, 23:386-392.
30. Nolan L.A., Nolan J.M., Shofer F.S., Rodway N.V., Emmett E.A. Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 2010, 29:147-155.
31. Shin H.M., Vieira V.M., Ryan P.B., Detwiler R., Sanders B., Steenland K., et al. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington works facility in West Virginia. Environ Sci Technol 2011, 45:1435-1442.
32. Shin H.M., Vieira V.M., Ryan P.B., Steenland K., Bartell S.M. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 2011, 119:1760-1765.
33. Parker S.E., Mai C.T., Canfield M.A., Rickard R., Wang Y., Meyer R.E., et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 2010, 88:1008-1016.
34. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., Lindstrom A.B., et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 2006, 90:510-518.